Thomas Edward Adams - 01 Jul 2022 Form 3/A - Amendment Insider Report for KORU Medical Systems, Inc. (KRMD)

Role: Interim CFO
Signature: /s/ Stephen Unger, Attorney-in-Fact
Issuer symbol: KRMD
Transactions as of: 01 Jul 2022
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 18 Apr 2023, 16:15:56 UTC
Date Of Original Report: 21 Jul 2022
Next filing: 03 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	KRMD	Common Stock						0	01 Jul 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	KRMD	Option to Purchase Shares of Common Stock							01 Jul 2022	Common Stock	200,000	$3.34	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares are subject to a 4 year vesting schedule. 25% of the Shares vest on the 1 year anniversary of the 12/01/2021 date of grant (the "Vesting Commencement Date"), and the remaining Shares vest as follows: 25% of the Shares at the end of each successive 12 month period following the Vesting Commencement Date.

Remarks:

This Form 3/A Amendment No. 1 is being filed to include the Reporting Person's Option to Purchase Shares of Common Stock in Table II, which were inadvertently omitted on the original Form 3 filing. The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.